AstraZeneca (LON:AZN) Stock Price Passes Above Two Hundred Day Moving Average - Time to Sell?

Key Points

• AstraZeneca's stock price has recently crossed above its 200-day moving average, reaching a high of £112.42 ($151.20) and last trading at £112.10 ($150.77).
• Analysts maintain a consensus rating of "Moderate Buy" for AstraZeneca, with price targets ranging from £110 to £142.
• Insider trading activity showed Aradhana Sarin sold over 9,500 shares at an average price of £115.12, totaling around £1.1 million.

Shares of AstraZeneca PLC (LON:AZN - Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of £109.10 ($146.73) and traded as high as £112.42 ($151.20). AstraZeneca shares last traded at £112.10 ($150.77), with a volume of 1,206,474 shares.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on AZN. Berenberg Bank restated a "buy" rating and set a £142 price objective on shares of AstraZeneca in a report on Monday, September 1st. Deutsche Bank Aktiengesellschaft restated a "hold" rating and set a £110 price objective on shares of AstraZeneca in a report on Wednesday, July 30th. Finally, Shore Capital reaffirmed a "buy" rating and issued a £135 target price on shares of AstraZeneca in a research report on Tuesday, July 29th. Three research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of £131.75.

AstraZeneca Stock Down 0.4%

The firm has a 50-day simple moving average of £114.21 and a 200 day simple moving average of £109.10. The company has a debt-to-equity ratio of 73.83, a current ratio of 0.93 and a quick ratio of 0.59. The company has a market capitalization of £173.78 billion, a PE ratio of 2,111.11, a price-to-earnings-growth ratio of 0.86 and a beta of 0.17.

Insider Buying and Selling

In other AstraZeneca news, insider Aradhana Sarin sold 9,563 shares of the firm's stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of £115.12, for a total value of £1,100,892.56. 0.14% of the stock is owned by company insiders.

AstraZeneca Company Profile

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.